Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06279364
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-02-19
Brief Title:
A Study of SKB264 Versus Investigators Choice Chemotherapy in Patients With Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer
Sponsor:
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Organization:
Sichuan Kelun Pharmaceutical Research Institute Co Ltd
Organization Data
Organization:
Sichuan Kelun Pharmaceutical Research Institute Co Ltd
Class:
INDUSTRY
Study ID:
SKB264-Ⅲ-11
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None